Cargando…

Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels

OBJECTIVE: To verify glomerular PLA2R antigen and serum PLA2R antibody expression in membranous nephropathy as well as to explore glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy (IMN) in the background of different serum anti-PLA2R levels. METHODS: We retro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yuemeng, Lan, Ping, Feng, Jie, Wang, Zhigang, Liu, Chao, Xie, Liyi, Yu, Xiaoyang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067982/ https://www.ncbi.nlm.nih.gov/pubmed/35484851 http://dx.doi.org/10.1080/0886022X.2022.2068442

Ejemplares similares

PLA2R antibodies and PLA2R glomerular deposits in psoriasis patients with membranous nephropathy
por: Ge, Yong-Chun, et al.
Publicado: (2016)

Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis
por: Li, Weiying, et al.
Publicado: (2018)

Serum anti-PLA2R antibody and glomerular PLA2R deposition in Chinese patients with membranous nephropathy: A cross-sectional study
por: Pang, Lu, et al.
Publicado: (2017)

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy
por: Hihara, Kei, et al.
Publicado: (2016)

Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis
por: Dai, Huanzi, et al.
Publicado: (2015)

The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

The application of podocyte antigen PLA2R and anti-PLA2R antibody in the diagnosis and treatment of membranous nephropathy
por: Chen, Yang, et al.
Publicado: (2023)

Response to immunosuppressive therapy in PLA(2)R- associated and non-PLA(2)R- associated idiopathic membranous nephropathy: a retrospective, multicenter cohort study
por: Wang, Jia, et al.
Publicado: (2017)

Membranous nephropathy PLA2R+ associated with Chagas disease
por: Xavier-Júnior, José Cândido Caldeira, et al.
Publicado: (2015)

The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017)

Horseshoe kidney with PLA2R-positive membranous nephropathy
por: Shi, Shuai-Shuai, et al.
Publicado: (2021)

Correction: The characters of antibodies against PLA2R in healthy individuals and in the patient with PLA2R associated membranous nephropathy
por: Cheng, Yan-jiao, et al.
Publicado: (2023)

Urine anti-PLA2R antibody is a novel biomarker of idiopathic membranous nephropathy
por: Wang, Yu, et al.
Publicado: (2017)

Association between PLA2R gene polymorphism and idiopathic membranous nephropathy in Heilongjiang Chinese
por: Tian, Tian, et al.
Publicado: (2023)

Anti-PLA(2)R Antibodies in Chinese Patients with Membranous Nephropathy
por: Li, Xin, et al.
Publicado: (2016)

Bortezomib Treatment for Refractory PLA2R-Positive Membranous Nephropathy
por: Geara, Abdallah S., et al.
Publicado: (2021)

The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis
por: Du, Yu, et al.
Publicado: (2014)

A rare case of PLA2R- and THSD7A-positive idiopathic membranous nephropathy
por: Wanderley, David Campos, et al.
Publicado: (2019)

The value of PLA2R antigen and IgG subclass staining relative to anti-PLA2R seropositivity in the differential diagnosis of membranous nephropathy
por: Bajcsi, Dóra, et al.
Publicado: (2023)

Anti-PLA2R1 Antibodies as Prognostic Biomarker in Membranous Nephropathy
por: Logt, Anne-Els van de, et al.
Publicado: (2021)

Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
por: Chen, Ruiying, et al.
Publicado: (2022)

Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease
por: Jagannathan, Geetha, et al.
Publicado: (2022)

PLA2R antibody, PLA2R rs4664308 polymorphism and PLA2R mRNA levels in Tunisian patients with primary membranous nephritis
por: Dhaouadi, Tarak, et al.
Publicado: (2020)

The cutoff value and prognosis of anti-PLA2R antibody for idiopathic membranous nephropathy: a single-center retrospective study in China
por: Guo, Hongxia, et al.
Publicado: (2023)

Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years
por: Pourcine, Franck, et al.
Publicado: (2017)

A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy
por: Liu, Xiaobin, et al.
Publicado: (2021)

Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role
por: Liu, Wenbin, et al.
Publicado: (2019)

Successful treatment of PLA(2)R1-antibody positive membranous nephropathy with ocrelizumab
por: Schmidt, Tilman, et al.
Publicado: (2020)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy
por: Kukuy, Olga Lesya, et al.
Publicado: (2023)

Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans
por: Lwezaula, Bingileki F, et al.
Publicado: (2021)

Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience
por: Porcelli, Brunetta, et al.
Publicado: (2020)

High-density Association Mapping and Interaction Analysis of PLA2R1 and HLA Regions with Idiopathic Membranous Nephropathy in Japanese
por: Thiri, Myo, et al.
Publicado: (2016)

Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
por: Ramachandran, R., et al.
Publicado: (2017)

Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy
por: Guo, Yaling, et al.
Publicado: (2020)

A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy
por: Zhang, Pingna, et al.
Publicado: (2021)

Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection
por: Baker, Lyle W., et al.
Publicado: (2021)

Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch
por: Fresquet, Maryline, et al.
Publicado: (2022)

Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults
por: Wu, Xueping, et al.
Publicado: (2018)

Serum Levels of BAFF and APRIL Predict Clinical Response in Anti-PLA2R-Positive Primary Membranous Nephropathy
por: Netti, Giuseppe Stefano, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kjhc4ogj5eafqmffj6amlpcv1f